Elihu Estey, MD, a world-class hematologist-oncologist, has been researching and treating AML for 40 years. Hear what he has to say on what is so rewarding about being a mentor in the field of hematology oncology as we caught up with him at the 2018 ASH Annual Meeting.
On December 1-4, the American Society of Hematology (ASH) will host its 60th annual meeting, showcasing important scientific insights from around the world. More than 50 world-class specialists, many whom treat patients at Seattle Cancer Care Alliance (SCCA), will be presenting their pioneering research. Visit us at exhibit booth 2657 through Monday, December 3.
Forty years ago, SCCA’s partner organization, Fred Hutch, pioneered the clinical use of bone marrow and stem cell transplantation. Since then, SCCA has been a leader in turning scientific discovery into exciting new treatments that are changing the way cancer is treated.
In 2005, while working as a forest ranger in Wisconsin, Ted Ave’Lallemant started feeling ill. His fever and exhaustion tailed him for three weeks until he visited his doctor.
Ave’Lallemant, who was 45, asked the doctor to take a close look at his lab results because, he told him, “I’ve been feeling crappy lately.”
That afternoon the doctor called with results of his blood analysis. “I’m pretty sure you have leukemia,” he said.
ASH President-Elect Stephanie Lee, MD, MPH, always planned to pursue a career in medicine. The SCCA hematologist and 22-year member of ASH recalls getting flustered during one medical school interview after being asked what she would do if she didn’t get into medical school.
“I hadn’t even thought of that as a possibility,” she says. “I was so certain that medicine was for me.”
Each year, the American Society of Hematology (ASH) recognizes members with high-achieving annual meeting abstracts, show leadership in diversity and have inspiring ideas for clinical hematology research. Congratulations to all of our Seattle Cancer Care Alliance members.
Janet Camp was looking forward to returning home to her farm outside Spokane after receiving an umbilical cord blood transplant, but she was uncertain about the health risks that may await her. Just over three months earlier, the 64-year-old retired teacher had received a transplant at Seattle Cancer Care Alliance (SCCA) to treat her acute lymphoblastic leukemia. Now Camp had questions about how to maintain her health back at the wheat and cattle farm. Was it safe to mow the lawn if she wore protective gear?
Alexes Harris was devastated when she was diagnosed with a rare form of leukemia. She was equally devastated to learn that as a woman of color, she didn’t have a bone marrow donor match.
Harris’ experiences with navigating her limited treatment options has transformed her into an advocate encouraging more people of color to join the national bone marrow donor registry. The University of Washington sociology professor has started by engaging the UW community.